Analyst stock forecast
Taysha Gene Therapies Forecast: $13.00 Analyst Target
Direct answer
Taysha Gene Therapies's average price target is $13.00.
The target implies +180.8% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +94.4%, the high target implies +310.4%, and the range spans 216% of the current price.
Forecast evidence checked October 5, 2026.
Get free Taysha Gene Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.63
- Average price target
- $13.00
- High price target
- $19.00
- Low price target
- $9.00
- Low target gap
- +94.4%
- Target upside
- +180.8%
- High target gap
- +310.4%
- Target range width
- 216%
- Consensus rating
- Strong Buy
- Analysts
- 13
- Evidence date
- October 5, 2026
- Valid through
- October 12, 2026
Explore related company data
Read the frequently asked questions.
What is Taysha Gene Therapies's average price target?
Taysha Gene Therapies's verified average price target is $13.00. The target range is $9.00 to $19.00.
How far are Taysha Gene Therapies's low and high targets from the recorded price?
The low target implies +94.4%, while the high target implies +310.4%.
How many analysts are included in Taysha Gene Therapies's consensus?
The verified consensus includes 13 analysts.
How is Taysha Gene Therapies's target upside or downside calculated?
The average target of $13.00 is divided by the recorded price of $4.63, then one is subtracted to produce +180.8%. This does not guarantee a future return.
When was Taysha Gene Therapies's analyst forecast verified?
The data was verified on 2026-10-05. The dataset is valid through 2026-10-12.